| 1998 |
GAB2 (p97) was cloned and identified as a scaffolding protein that, upon cytokine/growth factor/antigen receptor stimulation, becomes tyrosyl phosphorylated and associates with SHP2 and other SH2 domain-containing proteins. Expression of p97 mutants unable to bind SHP2 blocks cytokine-induced c-fos promoter activation, inhibiting Elk1-mediated and STAT5-mediated transactivation without inhibiting MAPK activation, revealing a novel pathway to immediate-early gene activation. |
Cloning, co-immunoprecipitation, dominant-negative mutant expression, reporter gene assays |
Molecular cell |
High |
9885561
|
| 1999 |
GAB2 contains an N-terminal pleckstrin homology (PH) domain and upon tyrosine phosphorylation physically interacts with SHP2 and GRB2. GAB2 has an inhibitory effect on Elk-1-dependent transcription triggered by dominant-active Ras or growth factor stimulation, while having a similar function to GAB1 in ERK activation, demonstrating uncoupling of ERK and Elk-1 signaling. |
Co-immunoprecipitation, reporter gene assays (Elk-1, SRE), dominant-active Ras overexpression |
The Journal of biological chemistry |
High |
10391903
|
| 2001 |
GAB2 is essential for mast cell allergic responses: Gab2-/- mice show defective FcεRI-induced degranulation and cytokine gene expression. GAB2 is the principal activator of PI3K downstream of FcεRI, as PI3K-dependent signaling pathways are defective in Gab2-/- mast cells. |
Gab2 knockout mice, mast cell functional assays (degranulation, cytokine production), passive cutaneous and systemic anaphylaxis models, biochemical pathway analysis |
Nature |
High |
11449275
|
| 2002 |
BCR-ABL recruits GAB2 via a GRB2/GAB2 complex through BCR-ABL Tyr177. GAB2 tyrosine phosphorylation enables association of PI3K and SHP2 with GAB2/BCR-ABL, activating PI3K/AKT and RAS/ERK pathways. Gab2-/- bone marrow myeloid progenitors are resistant to BCR-ABL transformation; lymphoid transformation is diminished with increased apoptosis. |
Gab2 knockout mice, BCR-ABL Y177F mutant, co-immunoprecipitation, bone marrow transformation assays, proliferation/migration assays |
Cancer cell |
High |
12124177
|
| 2001 |
GAB2 is required for mast cell development and KitL/c-Kit signaling. Gab2-deficient mice show markedly reduced mast cell numbers, and Gab2-deficient BMMCs show impaired KitL-induced ERK and AKT activation. |
Gab2 knockout mice, bone marrow-derived mast cell cultures, ERK/AKT phosphorylation assays |
Blood |
High |
11861309
|
| 2001 |
GAB2 acts as a scaffolding adapter downstream of the M-CSF receptor Fms: it associates with GRB2, SHP2, p85/PI3K, SHIP, and SHC upon M-CSF stimulation. GAB2 overexpression enhanced MAPK activity and macrophage differentiation; a SHP2-binding-defective mutant inhibited differentiation and increased proliferation, demonstrating that GAB2-SHP2 interaction is essential for M-CSF-induced differentiation signaling. |
Co-immunoprecipitation, GAB2 overexpression and dominant-negative mutants, MAPK assays, differentiation assays |
Molecular and cellular biology |
High |
11287610
|
| 2001 |
GAB2 regulates beta1-integrin signaling in hematopoietic cells: beta1 integrin cross-linking induces tyrosine phosphorylation of GAB2 and its association with Syk kinase, SHP-2, and PI3K p85. Overexpression of PH domain or SHP-2 binding-defective GAB2 mutants reduced cell adhesion, migration, and beta1-integrin-induced PI3K activation. |
Co-immunoprecipitation, GAB2 mutant overexpression, adhesion and migration assays, PI3K activity assays |
Blood |
Medium |
11895767
|
| 2001 |
GAB2 is a docking protein for SHP2 and PI3K downstream of the IL-2 receptor: phosphorylation of GAB2 depends on JAK3 (not Lck or Syk) and requires Tyr338 of the IL-2 receptor beta chain. GAB2 is the major SHP-2 and PI3K-associated 98-kDa protein in IL-2-activated lymphocytes; only IL-2 and IL-15 (not other gamma-c cytokines) induce GAB2 phosphorylation. |
Co-immunoprecipitation, IL-2 receptor mutants, JAK3 inhibition/knockout studies |
The Journal of biological chemistry |
High |
10849428
|
| 2001 |
GAB2 is phosphorylated by ZAP-70 in T cells and negatively regulates TCR signaling. GAB2 co-precipitates with ZAP-70, LAT, and CD3ζ upon TCR stimulation. Overexpression inhibits NF-AT activation and IL-2 production; inhibitory function requires SHP-2 binding sites and PI3K binding capacity. The PH domain is required for plasma membrane localization. |
Co-immunoprecipitation, GAB2 overexpression in Jurkat cells and T cell hybridomas, NF-AT reporter assays, GAB2 mutant analysis |
The Journal of biological chemistry |
High |
11572860
|
| 2002 |
PKB/AKT constitutively associates with GAB2 and phosphorylates GAB2 on Ser159, providing negative feedback: Ser159 phosphorylation inhibits GAB2 tyrosine phosphorylation. Gab2-S159A mutant enhances HRG-induced tyrosine phosphorylation, amplifies ERK and PKB pathway activation, increases ErbB2 tyrosine phosphorylation, and has potent transforming activity in fibroblasts, establishing GAB2 as a proto-oncogene. |
In vitro kinase assay (PKB phosphorylation of GAB2 at Ser159), site-directed mutagenesis (S159A), co-immunoprecipitation, focus-forming assay |
The EMBO journal |
High |
11782427
|
| 2002 |
GAB2 mediates a negative regulatory role in FcεRI signaling in mast cells: upon FcεRI aggregation, GAB2 translocates from cytosol to plasma membrane and associates with SHP2, GRB2, Lyn, and PLCγ. Overexpression of GAB2 inhibited FcεRI-induced phosphorylation of Syk and MAPK, calcium mobilization, degranulation, and TNF-α/IL-6 gene expression, while leaving Akt phosphorylation unaffected. |
Co-immunoprecipitation, GAB2 overexpression in RBL-2H3 cells, calcium mobilization assay, degranulation assay, cytokine mRNA analysis |
Journal of immunology |
Medium |
11971018
|
| 2002 |
GAB2 interacts with SHP-2 via specific tyrosines: Y452, Y476, and Y584 mediate p85-PI3K binding; Y614 exclusively mediates SHP-2 binding; Y266 and Y293 mediate CrkL binding (via CrkL SH2). These interactions were mapped using a yeast two-hybrid system with Lyn kinase co-expression. |
Modified yeast two-hybrid with Lyn tyrosine kinase co-expression, tyrosine mutants |
FEBS letters |
Medium |
11334882
|
| 2002 |
In BCR-ABL+ K562 CML cells, GAB2 overexpression selectively activates the Erk2-Elk1 signaling pathway in a manner dependent on GAB2 Tyr604 (SHP2 docking site) and SHP2 phosphatase activity. Induced GAB2 expression promotes Erk activation, growth arrest, and megakaryocytic differentiation. |
Erk2-Elk1 reporter assays, inducible Gab2 expression, GAB2 Y604F mutant analysis, differentiation markers |
Blood |
Medium |
11830491
|
| 2003 |
GAB2 is required for FcγR-mediated phagocytosis in macrophages: upon FcγR activation, GAB2 becomes tyrosyl phosphorylated, associates with PI3K p85 and SHP2, and is recruited to the nascent phagosome where PI3K lipid production occurs. Gab2-/- macrophages show severely impaired FcγR phagocytosis correlating with decreased Akt activation. PH domain and GRB2-binding site of GAB2 are required for phagosome recruitment, and phagosome localization is sensitive to PI3K inhibition. |
Gab2 knockout mice, confocal fluorescence microscopy, co-immunoprecipitation, phagocytosis assays, wortmannin treatment, GAB2 mutant analysis |
The Journal of cell biology |
High |
12821647
|
| 2003 |
GAB2 interacts with GC-GAP, a RhoA/Rac1/Cdc42 GTPase-activating protein, through its middle region. This interaction was identified by yeast two-hybrid screening and GC-GAP reduces active Rac1 and Cdc42 levels, suggesting GAB2 may regulate Rho family GTPase activity through GC-GAP recruitment. |
Yeast two-hybrid, co-immunoprecipitation, in vitro GAP activity assay, siRNA knockdown |
The Journal of biological chemistry |
Medium |
12819203
|
| 2003 |
GAB2 inhibitory function in T cells requires Gads/Grb2-mediated association with LAT. The MBD domain of GAB2 contains a PXXXR motif that is critical for constitutive association with Gads/Grb2, which recruits GAB2 to lipid rafts after TCR ligation. Gab2-deficient T cells show enhanced proliferative responses to TCR stimulation. |
Gab2 knockout mice, GAB2 mutant analysis, co-immunoprecipitation, lipid raft fractionation, T cell transgenic mice |
Molecular and cellular biology |
High |
12640133
|
| 2003 |
In T cells, GAB2 delivers an inhibitory signal via PI3K: overexpression of GAB2 inhibits TCR-evoked IL-2 promoter activation (blocking NF-AT and NF-κB transcription). Inhibition is abrogated by mutating GAB2 p85-binding sites or by PI3K inhibitor treatment. |
GAB2 overexpression in T cell lines, reporter gene assays (IL-2 promoter, NF-AT, NF-κB), PI3K inhibitors, GAB2 p85-binding site mutants |
Journal of immunology |
Medium |
11035047
|
| 2004 |
SHP2 binds GAB2 at Tyr614 via its N-terminal SH2 domain (and Tyr643 via C-terminal SH2, though Y614F mutation alone prevents SHP2 recruitment). This SHP2-GAB2 interaction is required for ERK activation and c-fos SRE transcriptional induction in response to IL-2. GAB2/SHP2-mediated ERK activation and Rho-dependent signals cooperate for full SRE induction. |
Co-immunoprecipitation with Tyr→Phe mutants, ERK activation assays, SRE reporter assays, dominant-active/dominant-negative RhoA |
The Biochemical journal |
Medium |
15170389
|
| 2004 |
Hematopoietic cell kinase (Hck) phosphorylates GAB1 and GAB2 in response to IL-6, and this Src-family kinase-dependent phosphorylation is required for IL-6-induced ERK and AKT activation and multiple myeloma cell proliferation/survival. |
Src family kinase inhibitor PP2, kinase-inactive Hck mutants, kinase assays, proliferation/survival assays |
The Journal of biological chemistry |
Medium |
15010462
|
| 2005 |
GAB2 is the principal scaffold for RANK-induced NF-κB, Akt, and Jnk activation in osteoclastogenesis. Gab2-/- mice develop osteopetrosis with defective osteoclast differentiation. GAB2 associates with RANK and mediates RANK signaling to these downstream pathways. |
Gab2 knockout mice (osteopetrosis phenotype), co-immunoprecipitation with RANK, osteoclast differentiation assays, NF-κB/Akt/Jnk signaling assays |
Nature medicine |
High |
15750601
|
| 2005 |
In breast cancer, GAB2 overexpression increases proliferation and invasion of mammary epithelial cells; invasive phenotype with HER2 (Neu) is mediated by hyperactivation of the SHP2-ERK pathway. Gab2 deficiency ameliorates Neu-evoked breast carcinogenesis in mice. |
3D Matrigel culture, co-expression with Neu, Gab2 knockout in Neu-transgenic mouse model, signaling pathway analysis |
Nature medicine |
High |
16369543
|
| 2005 |
GAB2 overexpression in MCF-10A cells enhances EGF-induced ERK and AKT activation, increases acinar size in 3D culture dependent on GRB2 and SHP2 binding, and overcomes EGF dependence. A GAB2 mutant unable to bind p85/PI3K has reduced effect on acinar size. These effects establish GAB2 as an amplifier of RTK signaling. |
3D Matrigel morphogenesis assay, GAB2 mutants (Grb2 binding, Shp2 binding, p85 binding), pharmacological MEK inhibition, signaling assays |
The Journal of biological chemistry |
High |
16253990
|
| 2005 |
Activated STAT5 promotes constitutive GAB2 tyrosine phosphorylation independent of JAK2, and GAB2 forms a complex with STAT5, p85/PI3K, and GRB2 (but not SHP2) in this context. A GAB2 mutant lacking PI3K binding sites (3YF) inhibits caSTAT5-induced proliferation, survival, and ERK/AKT activation, establishing GAB2 as essential for STAT5-driven PI3K/Akt and Ras/MAPK signaling. |
Co-immunoprecipitation, GAB2-3YF mutant overexpression, constitutively active STAT5 expression, proliferation/survival assays |
The Biochemical journal |
Medium |
15833084
|
| 2006 |
PLCγ2 forms a complex with GAB2 in osteoclasts, is required for RANKL-mediated phosphorylation of GAB2, and modulates GAB2 recruitment to RANK. PLCγ2-dependent NFATc1 upregulation (but not JNK and NF-κB) requires Dap12/FcRγ receptors and is blocked by PLCγ inhibitor. PLCγ2 deletion results in osteopetrosis. |
Plcg2 knockout mice, co-immunoprecipitation, PLCγ inhibitor U73122, osteoclast differentiation assays, NFATc1 activation assays |
The Journal of clinical investigation |
High |
17053833
|
| 2006 |
GAB2 requires SHP2 to activate the Rac/JNK pathway downstream of Kit Tyr567 in mast cells for SCF-evoked proliferation. GAB2 becomes tyrosyl-phosphorylated and associates with Kit and SHP2 upon Kit activation. SFK activity (via Tyr567) is required for GAB2 tyrosyl phosphorylation and SHP2 association. GAB2 acts in a parallel pathway to PI3K from Kit Tyr719. |
Gab2-/- mast cells, Gab2/SHP2 double conditional knockouts, compound Gab2-/-:KitY719F/Y719F mice, GAB2 mutants (SHP2-binding defective), JNK/Rac activation assays |
The Journal of biological chemistry |
High |
16873377
|
| 2007 |
GAB2 knockdown increases tau phosphorylation in neurons, suggesting GAB2 negatively regulates tau phosphorylation. GAB2 protein is detected in neurons, tangle-bearing neurons, and dystrophic neurites in Alzheimer's disease brain. |
siRNA knockdown of GAB2, immunohistochemistry/immunofluorescence in human brain tissue |
Neuron |
Low |
17553421
|
| 2007 |
GAB2 is required for mammary tumor metastasis downstream of Neu/ErbB2: Gab2-/- cancer cells show decreased migration and impaired ERK activation; defects are rescued by re-introduction of Gab2. Gab2 ablation severely suppresses lung metastasis with normal Akt activity, indicating a specific role for GAB2-ERK in metastasis. |
Gab2 knockout in Neu-transgenic mouse breast cancer model, GAB2 re-expression rescue, migration assays, ERK/AKT signaling assays, lung metastasis quantification |
Oncogene |
High |
17310989
|
| 2007 |
A novel Stat3 binding site in Gab2 mediates activation of Stat3 by Sf-Stk receptor tyrosine kinase (Friend virus-associated). Grb2-mediated recruitment of GAB2 (but not GAB1) to Sf-Stk supports expansion of infected erythroid progenitors. Gab2-/- mice are less susceptible to Friend erythroleukemia. |
Gab2 knockout mice, Sf-Stk/Gab2 fusion proteins, Stat3 reporter assays, co-immunoprecipitation |
Molecular and cellular biology |
Medium |
16314834 17353274
|
| 2008 |
14-3-3 proteins bind GAB2 at growth factor-induced phosphorylation sites Ser210 and Thr391, providing negative feedback. The Gab2-S210A/T391A double mutant shows sustained receptor association and signaling and promotes cell proliferation and transformation. Introduction of constitutive 14-3-3 binding sites into GAB2 renders it refractory to receptor activation. 14-3-3 binding reduces Grb2 association, uncoupling GAB2 from the receptor complex. |
Mass spectrometry phosphoproteomics, site-directed mutagenesis (S210A/T391A), constitutive 14-3-3 binding site knock-in, co-immunoprecipitation, proliferation/transformation assays |
The EMBO journal |
High |
19172738
|
| 2008 |
Lyn kinase (BCR-ABL-independent) forms a complex with GAB2 and c-Cbl in imatinib-resistant CML cells and mediates persistent GAB2 and BCR-ABL tyrosine phosphorylation. Lyn silencing or inhibition is required to suppress GAB2 phosphorylation and recover imatinib sensitivity. |
Co-immunoprecipitation, siRNA knockdown, Lyn kinase inhibitors, imatinib sensitivity assays in CML cells and patient samples |
Blood |
Medium |
18235045
|
| 2008 |
GAB2 is involved in differential PI3K signaling by two splice forms of c-Kit (GNNK- vs GNNK+): GNNK- c-Kit mediates stronger PI3K/AKT activation dependent on GAB2 association. Src-mediated phosphorylation of GAB2 is independent of direct PI3K association with c-Kit. siRNA knockdown of GAB2 confirms its role in c-Kit-induced PI3K/AKT activation. |
siRNA knockdown of Gab2, c-Kit splice variant expression, co-immunoprecipitation, PI3K/AKT activation assays, Src inhibitor studies |
The Journal of biological chemistry |
Medium |
18697750
|
| 2009 |
Two distinct epitopes in GAB2 (Gab2a and Gab2b) bind the Grb2 SH3C domain with different binding modes. Crystal structures reveal that Gab2b contains a 3(10) helix positioning an RxxK motif, while Gab2a contains the RxxK motif in a PPII helix. These define the molecular basis of GAB2-GRB2 interaction. |
Crystal structures of Gab2a/Grb2SH3C and Gab2b/Grb2SH3C complexes, isothermal titration calorimetry, peptide arrays |
Structure |
High |
19523899
|
| 2009 |
GAB2-mediated signaling promotes melanoma metastasis via PI3K-AKT hyperactivation. GAB2 overexpression potentiates migration and invasion; knockdown reduces them. PI3K-AKT pathway inhibition decreases GAB2-mediated tumor cell migration. GAB2 overexpression enhances in vivo tumor growth and metastasis. |
GAB2 siRNA knockdown, GAB2 overexpression, PI3K inhibitor treatment, in vitro migration/invasion assays, in vivo xenograft model |
The American journal of pathology |
Medium |
19342374
|
| 2009 |
RANK contains a highly conserved domain (HCR) that recruits GAB2, which then associates with PLCγ2, mediating sustained NF-κB activation and PLCγ2/NFATc1 activation during late-phase RANK signaling essential for osteoclastogenesis. |
Co-immunoprecipitation with RANK HCR domain mutants, RANK-deletion constructs, NF-κB and NFATc1 reporter assays, osteoclast differentiation |
Genes to cells |
Medium |
19845770
|
| 2010 |
GAB2 suppresses RhoA activation via SHP2-dependent promotion of Vav2 phosphorylation and p190A RhoGAP plasma membrane recruitment. GAB2 overexpression decreases stress fibers and focal adhesions and enhances migration; effects are reversed by constitutively active RhoA or p190A RhoGAP knockdown. Both SHP2 binding sites in GAB2 are required for these effects. |
GAB2 overexpression, GAB2 mutants (SHP2-binding site mutations), RhoA/Rac-GTP pull-down assays, constitutively active RhoA rescue, p190A RhoGAP knockdown, cell morphology/migration assays |
Molecular biology of the cell |
High |
21118992
|
| 2011 |
GAB2 via PI3K regulates ARF1 activation downstream of FcεRI for granule translocation in mast cell degranulation. GAB2 knock-in mice (mutated at PI3K or SHP2 binding sites) show both sites required for degranulation and anaphylaxis; PI3K (not SHP2) binding site is required for granule translocation. Fyn and GAB2/PI3K upstream of ARF1 constitute the pathway. SHP2 binding site is dispensable for granule translocation but required for degranulation. |
GAB2 knock-in mice (PI3K-binding-defective and SHP2-binding-defective), ARF1 activation assay, FcεRI degranulation assays, anaphylaxis model |
Journal of immunology |
High |
21653832
|
| 2011 |
G-CSF activates Lyn kinase through a Gab2-Shp2 complex: after G-CSF stimulation, Lyn dynamically associates with Gab2; Shp2 recruited by Gab2 dephosphorylates inhibitory phospho-Lyn Tyr507 to activate Lyn. A GAB2 mutant unable to bind Shp2 prevents Tyr507 dephosphorylation. |
Co-immunoprecipitation, Shp2-deficient cells, Shp2E76A constitutively active mutant, in vitro dephosphorylation assay, GAB2 Shp2-binding mutant |
Blood |
High |
21636860
|
| 2011 |
In ovarian cancer cells, GAB2 promotes migration, invasion, and EMT via activation of the PI3K pathway. GAB2 inhibits E-cadherin expression and enhances Zeb1 expression through PI3K, not the Shp2-ERK pathway; Zeb1 knockdown blocks GAB2-induced E-cadherin suppression and invasion. |
GAB2 overexpression and knockdown, GAB2 mutants (PI3K-binding defective, SHP2-ERK pathway defective), Zeb1 knockdown, PI3K inhibitors (LY294002, GDC-0941, rapamycin), migration/invasion assays |
Oncogene |
High |
21996746
|
| 2012 |
PKA phosphorylates GAB2 on Ser159, and GAB2 acts as an A-kinase anchoring protein that binds the type I regulatory subunit of PKA. GAB2 is present in a preformed complex with PI3K heterodimer and IRS-1 in granulosa cells. GAB2 overexpression enhances FSH-stimulated AKT phosphorylation, connecting cAMP-PKA signaling to the PI3K/AKT pathway. |
Co-immunoprecipitation (PKA regulatory subunit with GAB2), GAB2 overexpression, FSH-stimulated AKT phosphorylation assays |
Proceedings of the National Academy of Sciences of the United States of America |
Medium |
23045700
|
| 2013 |
RSK (p90 ribosomal S6 kinase) phosphorylates GAB2 on three conserved basic consensus residues in vitro and in vivo, inhibiting SHP2 recruitment to GAB2 without affecting GRB2 binding. An unphosphorylatable GAB2 mutant promotes invasion-like phenotype and increased cell motility, establishing RSK as a negative-feedback kinase for GAB2-SHP2 signaling. |
In vitro kinase assay (RSK phosphorylating GAB2), mass spectrometry phosphorylation site mapping, site-directed mutagenesis, co-immunoprecipitation, cell motility assays |
Molecular and cellular biology |
High |
23401857
|
| 2015 |
A small-molecule (ISIR-005) stabilizes the 14-3-3/GAB2 protein-protein interaction by binding at the rim of the interface near the Gab2pT391 binding site. Crystal structure reveals ISIR-005 occupies a pre-formed pocket only at the pT391 site (not the pS210 site), providing structural proof of druggability of this interaction. |
Crystal structure of ISIR-005/14-3-3/Gab2pS210pT391, isothermal titration calorimetry |
ChemMedChem |
High |
26644359
|
| 2016 |
GAB2 interaction with mutant SHP2 (E76K/D61Y) is enhanced, and the Gab2/PI3K/mTOR pathway is elevated in Ptpn11E76K/+ leukemic cells. Double mutant Ptpn11E76K/+/Gab2-/- mice show markedly attenuated myeloproliferative neoplasia, normalized myeloid differentiation, and prolonged survival. Rapamycin treatment mitigates MPN phenotypes, confirming the mTOR pathway mediates pathogenic signaling. |
Ptpn11E76K/+/Gab2-/- double mutant mice, rapamycin treatment, co-immunoprecipitation, myeloid colony assays, histology |
Leukemia |
High |
27840422
|
| 2016 |
In BCR-ABL1 leukemogenesis, distinct GAB2 signaling pathways are required for myeloid vs. lymphoid transformation: both PI3K and SHP2 binding sites of GAB2 are required for CML pathogenesis, while only the SHP2 binding site is essential for lymphoid leukemogenesis. Gab2-/- mice fail to develop CML-like disease after BCR-ABL1 transduction. |
Gab2-/- mouse models of CML and B-ALL, GAB2 mutants (PI3K binding-defective, SHP2 binding-defective), GAB2 re-expression rescue, signaling analysis |
Blood |
High |
26773044
|
| 2017 |
YAP/TAZ transcription regulators upregulate GAB2 expression; coordinate knockdown of YAP and TAZ markedly decreases GAB2 protein levels and reduces PI3K pathway activation in endometrial cancer cells, establishing a HIPPO-YAP/TAZ-GAB2-PI3K signaling axis. |
siRNA knockdown of YAP and TAZ, GAB2 protein level measurement, PI3K/AKT pathway assays, in vivo tumor growth |
Cancer research |
Medium |
28202507
|
| 2017 |
GAB2 overexpression in zebrafish MYCN-transgenic neuroblastoma activates the SHP2-RAS-ERK pathway, enhances neuroblastoma induction, and increases tumor penetrance. GAB2 functions as an activator of SHP2 that cooperates with MYCN in neuroblastomagenesis. |
Zebrafish MYCN transgenic model with Gab2 overexpression, ERK pathway activation analysis, tumor penetrance/latency assessment |
Cell reports |
Medium |
28329685
|
| 2017 |
Gab1 and Gab2 are recruited to the IL-4 receptor and synergistically enhance IL-4 downstream signaling but confer IL-4 signal preference in macrophages. Loss of Gab2 specifically suppresses STAT6 activation (while Gab1 loss attenuates AKT) in response to IL-4, defining non-redundant roles in M2 polarization. |
Gab2-/- mice, Gab1 conditional knockout in macrophages, IL-4 signaling assays (STAT6, AKT), M2 polarization markers, bleomycin fibrosis model, co-immunoprecipitation with IL-4 receptor |
The Journal of biological chemistry |
High |
28687632
|
| 2022 |
GAB2 facilitates assembly of the CBM (CARMA3-BCL10-MALT1) signalosome in endothelial cells, mediating Rho and NF-κB activation downstream of IL-1β. GAB2 silencing or MALT1 inhibition reduces IL-1β-induced Rho-dependent P-selectin/VWF exocytosis and NF-κB-dependent tissue factor expression. Gab2 deficiency suppresses venous thrombosis in IVC ligation mouse models. |
siRNA knockdown of Gab2 and MALT1, MALT1 pharmacological inhibitor (mepazine), co-immunoprecipitation (CBM signalosome assembly), endothelial exocytosis/adhesion assays, IVC ligation stenosis/stasis mouse models |
Blood |
High |
35895897
|